These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 18639776)

  • 41. Diagnosis and treatment of heartburn. An update on therapies.
    Wright W
    Adv Nurse Pract; 2010 Apr; 18(4):24-9; quiz 30. PubMed ID: 20486300
    [No Abstract]   [Full Text] [Related]  

  • 42. Complete atrioventricular block and cardiac arrest following intravenous famotidine administration.
    Schoenwald PK; Sprung J; Abdelmalak B; Mraović B; Tetzlaff JE; Gurm HS
    Anesthesiology; 1999 Feb; 90(2):623-6. PubMed ID: 9952172
    [No Abstract]   [Full Text] [Related]  

  • 43. Proton-pump inhibitor vs. H2-receptor blocker use and overall risk of CKD progression.
    Cholin L; Ashour T; Mehdi A; Taliercio JJ; Daou R; Arrigain S; Schold JD; Thomas G; Nally J; Nakhoul NL; Nakhoul GN
    BMC Nephrol; 2021 Jul; 22(1):264. PubMed ID: 34266395
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anaphylactic reaction after the concomitant intravenous administration of corticosteroids and gastroprotective drugs: two case reports.
    Ventura MT; Buquicchio R; Cecere R; Calogiuri G; Cannito CD; De Donno M; Maietta G
    J Biol Regul Homeost Agents; 2013; 27(2):589-94. PubMed ID: 23830408
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Proton pump inhibitor use is not associated with cardiac arrhythmia in critically ill patients.
    Chen KP; Lee J; Mark RG; Feng M; Celi LA; Malley BE; Danziger J
    J Clin Pharmacol; 2015 Jul; 55(7):774-9. PubMed ID: 25655574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro evaluation of phototoxic properties of proton pump inhibitors, H2-receptor antagonists and statins.
    Gebhardt E; Eberlein B; Przybilla B; Gilbertz KP; Placzek M
    Acta Derm Venereol; 2012 Mar; 92(2):208-10. PubMed ID: 22002635
    [No Abstract]   [Full Text] [Related]  

  • 47. Proton Pump Inhibitor and H2 Blocker-Associated Acute Interstitial Nephritis in a Renal Allograft.
    Bhat ZY; Haroon N; Singh A
    Am J Ther; 2018; 25(5):e563-e565. PubMed ID: 29023281
    [No Abstract]   [Full Text] [Related]  

  • 48. Association of Proton Pump Inhibitor/Histamine-2 Blocker Use and Ocular Toxoplasmosis: Findings from a Large US National Database.
    Conrady CD; Pradeep T; Yu Y; Johnson MW; VanderBeek BL
    Ophthalmol Retina; 2023 Mar; 7(3):261-265. PubMed ID: 36058521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H
    Gao J; Ma S; Xu S; Chen M
    Dis Markers; 2022; 2022():4093595. PubMed ID: 35801003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proton-Pump Inhibitors and Risk of Calcium Pyrophosphate Deposition in a Population-Based Study.
    Liew JW; Peloquin C; Tedeschi SK; Felson DT; Zhang Y; Choi HK; Terkeltaub R; Neogi T
    Arthritis Care Res (Hoboken); 2022 Dec; 74(12):2059-2065. PubMed ID: 35245410
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Famotidine augmentation in schizophrenia: hope or hype?
    Andrade C
    J Clin Psychiatry; 2013 Sep; 74(9):e855-8. PubMed ID: 24107771
    [No Abstract]   [Full Text] [Related]  

  • 52. Is oral combination therapy with a proton-pump inhibitor and H2 receptor antagonist effective as initial treatment?
    Inamori M; Akimoto K; Akiyama T; Fujita K; Takahashi H; Yoneda M; Abe Y; Kirikoshi H; Kubota K; Saito S; Ueno N; Nakajima A
    J Gastroenterol; 2007 Jun; 42(6):510-1. PubMed ID: 17671771
    [No Abstract]   [Full Text] [Related]  

  • 53. [Long-term proton pump inhibitor therapy: beware of vitamin B 12 deficiency].
    Füessl HS
    MMW Fortschr Med; 2014 Mar; 156(5):34. PubMed ID: 24912265
    [No Abstract]   [Full Text] [Related]  

  • 54. Famotidine-associated delirium. A series of six cases.
    Catalano G; Catalano MC; Alberts VA
    Psychosomatics; 1996; 37(4):349-55. PubMed ID: 8701013
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Adverse effects of gastric acid suppressive drugs].
    Haruma K; Kamada T; Shiotani A
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():198-201. PubMed ID: 18074539
    [No Abstract]   [Full Text] [Related]  

  • 56. Histamine 2 Receptor Antagonists and Proton Pump Inhibitors.
    Brinkworth MD; Aouthmany M; Sheehan M
    Dermatitis; 2016; 27(3):100-9. PubMed ID: 27172303
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Esophageal hyperkeratosis after proton pump inhibitor therapy in a patient with esophageal eosinophilia.
    Molina-Infante J; Ferrando-Lamana L; Vinagre-Rodriguez G
    Gastrointest Endosc; 2013 Jan; 77(1):131-2. PubMed ID: 23261103
    [No Abstract]   [Full Text] [Related]  

  • 58. [Nosocomial pneumonia during stress ulcer prophylaxis? - risk of nosocomial pneumonia is increased during stress ulcer prophylaxis].
    Madisch A
    Dtsch Med Wochenschr; 2013 Nov; 138(47):2398. PubMed ID: 24221973
    [No Abstract]   [Full Text] [Related]  

  • 59. Allergic reaction to proton pump ınhibitor: pantoprazole induced Kounis syndrome.
    Canpolat U; Şahiner L; Aytemir K; Oto A
    Int J Cardiol; 2012 Aug; 159(2):e27-8. PubMed ID: 22192298
    [No Abstract]   [Full Text] [Related]  

  • 60. Proton Pump Inhibitors and Risk of Cardiovascular Disease: A Self-Controlled Case Series Study.
    Park JY; Yoo J; Jeon J; Kim J; Kang S
    Am J Gastroenterol; 2022 Jul; 117(7):1063-1071. PubMed ID: 35505518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.